“Next Steps in Speeding Up the Drug Development Process…”

This week, Jeremy is joined by co-host Jessica Chapman to get an update on all the work being done to speed up the process of getting promising new treatments to people with ALS. They turn to Abram Bieliauskas, associate director of government affairs for The ALS Association, and Dave Zook, a consultant for the Association. Dave and Abram reflect on the recent We Can’t Wait Action Meeting with the FDA and lay out two promising bills recently reintroduced in Congress – the Promising Pathways Act and ACT for ALS.

It’s not too late to register for the 2021 virtual advocacy conference: http://www.alsadvocacyconf.org/

To learn more about the fight to expand access to promising treatments go to https://www.als.org/advocacy/we-cant-wait

Sign up to become an ALS advocate at https://als.quorum.us/register/

Find out more information about The ALS Association’s public policy priorities at https://www.als.org/advocacy/our-priorities

This episode was produced by Garrett Tiedemann and is brought to you by The ALS Association’s national office and the Association’s Minnesota/North Dakota/South Dakota Chapter